Pharmacokinetics: absorption, distribution, clearance
What the body does to a drug: bioavailability, volume of distribution, clearance, half-life, loading and maintenance doses, and the first-order and zero-order kinetics behind them.
By the end of this page you should be able to
- Define bioavailability and explain the factors that affect absorption by each route.
- Define volume of distribution and clearance, and relate them to half-life.
- Interpret a log concentration-time curve after an IV bolus and identify the distribution and elimination phases.
- Calculate a loading dose and a maintenance dose, and predict the time to steady state.
- Distinguish first-order and zero-order kinetics, with clinical examples.
Absorption and bioavailability
Bioavailability (F) is the fraction of an administered dose that reaches the systemic circulation unchanged. It is 1 for IV drugs by definition and is measured as the oral AUC ÷ IV AUC (dose-corrected).
Most drugs cross membranes by passive diffusion of the un-ionised, lipid-soluble form. Weak acids are less ionised in acid; weak bases less ionised in alkali (Henderson-Hasselbalch). In practice the small intestine absorbs most drugs, acid or base, because of its huge surface area and blood flow.
- First-pass metabolism: drug absorbed from the gut goes via the portal vein through the liver (and gut wall enzymes such as CYP3A4) before reaching the systemic circulation. High first-pass drugs: morphine, GTN, propranolol, lignocaine, midazolam. Sublingual, buccal, rectal (partly), transdermal, intranasal and parenteral routes avoid it.
- Formulation and gut factors: dissolution, gastric emptying (delayed by opioids, anticholinergics, shock), food, gut motility, efflux pumps (P-glycoprotein).
- IM and subcutaneous absorption depends on local blood flow: poor in shock and cold peripheries, which is why IM adrenaline in anaphylaxis goes into the vascular thigh muscle.
- Inhaled drugs act locally with little systemic effect; much of a nebulised dose is swallowed.
Distribution and volume of distribution
Volume of distribution (Vd) is the apparent volume into which a drug would have to dissolve to give the observed plasma concentration: Vd = amount in body ÷ plasma concentration. It is not a real anatomical space. Drugs that bind tissue heavily (amiodarone, tricyclics, digoxin, chloroquine) have a Vd far larger than total body water; drugs confined to plasma or ECF (heparin, gentamicin, warfarin) have a small one.
What drives Vd: lipid solubility, ionisation, plasma protein binding (keeps drug in plasma, lowers Vd) and tissue binding (raises Vd). Albumin binds acidic drugs (warfarin, phenytoin, salicylate); alpha-1 acid glycoprotein binds basic drugs (lignocaine, propranolol) and rises after surgery and trauma.
Two clinical uses: Vd decides the loading dose, and a small Vd (under about 1 L/kg) is one of the conditions for a drug to be removed usefully by haemodialysis (with low protein binding and low molecular weight: lithium, salicylate, toxic alcohols, metformin, valproate at high levels).
Clearance and half-life
Clearance (CL) is the volume of plasma completely cleared of drug per unit time: rate of elimination = CL × plasma concentration. Total clearance is the sum of hepatic, renal and other clearances.
Hepatic clearance = hepatic blood flow × extraction ratio. High extraction drugs (above 0.7: lignocaine, propranolol, morphine, GTN) are flow-limited: clearance falls when hepatic blood flow falls (shock, heart failure, beta blockers). Low extraction drugs (below 0.3: warfarin, phenytoin, theophylline, diazepam) are capacity-limited: clearance depends on enzyme activity and free fraction, so enzyme induction, inhibition and protein binding changes matter.
Half-life depends on both: t½ = 0.693 × Vd ÷ CL. A drug with a big Vd has a long half-life even if cleared efficiently. Half-life tells you how long a drug takes to fall, and how long to reach steady state.
Compartments and the concentration-time curve
After an IV bolus, plasma concentration on a log scale often shows two phases. The steep early distribution (alpha) phase is drug moving from plasma into tissues; the later straight elimination (beta) phase is removal from the body. The half-life usually quoted is the elimination half-life, from the slope of the beta line (k = 0.693 ÷ t½).
For drugs like propofol and fentanyl, the end of a single dose's effect comes from redistribution, not elimination. With a long infusion, peripheral tissues fill up, and offset slows: the context-sensitive half-time (time for the plasma concentration to halve after stopping an infusion of given duration) rises with infusion length.
Dosing: loading, maintenance and steady state
- Loading dose = target concentration × Vd ÷ F. Fills the volume quickly. Independent of clearance. Used for amiodarone, digoxin, phenytoin, vancomycin, aminoglycosides.
- Maintenance dose rate = target concentration × CL ÷ F. Replaces what is eliminated. Reduce it when clearance falls (renal or hepatic failure); the loading dose usually stays the same.
- Steady state is reached after about 4 to 5 half-lives of a constant dosing regimen (94% after 4, 97% after 5), whatever the dose. A loading dose gets there sooner; it does not change where steady state is.
- The same rule tells you elimination: after 4 to 5 half-lives, more than 90% of the drug has gone (first-order drugs only).
First-order and zero-order kinetics
First-order: a constant fraction is eliminated per unit time; rate is proportional to concentration; half-life is constant; log concentration falls in a straight line. Most drugs at therapeutic doses.
Zero-order (saturation) kinetics: a constant amount is eliminated per unit time, because the enzymes are saturated; half-life lengthens as concentration rises; small dose increases cause large, unpredictable rises in level. Examples: ethanol (at almost all concentrations), phenytoin (within the therapeutic range), salicylate and paracetamol in overdose, and thiopentone at high doses. Michaelis-Menten kinetics describe the transition: first-order well below Km, zero-order well above it.
Making the answer flow
- Lead with the definition and the equation, then the clinical consequence: "Vd is the amount in the body divided by plasma concentration; it determines the loading dose."
- Draw the log concentration-time curve and point to the two phases.
- Use renal failure as the test case: loading dose unchanged, maintenance dose reduced, time to steady state longer.
Where marks are lost
- Saying a loading dose depends on clearance, or a maintenance dose on Vd.
- Treating Vd as a real body compartment.
- Saying a loading dose changes the eventual steady-state concentration.
- Calling all overdoses zero-order. Many drugs stay first-order even in overdose.
Where this meets the emergency department
- In shock, IM and subcutaneous absorption is unreliable; give resuscitation drugs IV or IO.
- Dialysable poisons share small Vd, low protein binding and low molecular weight: lithium, salicylate, toxic alcohols and metformin are the ones to think of.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Define volume of distribution. Why does amiodarone have such a large one, and what does that mean for dosing?
Show answer
- Vd = amount of drug in the body ÷ plasma concentration; an apparent volume.
- Amiodarone is highly lipid soluble and binds extensively to tissues (fat, muscle, liver, lung); Vd is many times total body water (around 60 L/kg).
- Needs a loading dose to achieve effect; very long elimination half-life (weeks to months) because t½ = 0.693 × Vd ÷ CL.
- Early IV effect depends on distribution to the heart, not total body loading.
- 2.
What is bioavailability and what factors reduce it after an oral dose?
Show answer
- Fraction of an administered dose reaching systemic circulation unchanged; AUC oral ÷ AUC IV.
- Pharmaceutical: formulation, dissolution, particle size.
- Patient: gastric emptying, gut motility, food, gut wall metabolism (CYP3A4), P-glycoprotein efflux, first-pass hepatic metabolism, gut disease.
- Drug: ionisation, lipid solubility, instability in acid (benzylpenicillin).
- Examples of high first pass: morphine (about 30%), GTN (near zero, so sublingual).
- 3.
A patient with acute kidney injury needs gentamicin. How do you adjust the dose?
Show answer
- Gentamicin: polar, small Vd (about ECF), renally excreted unchanged.
- Loading (first) dose depends on Vd and should not be reduced; underdosing in sepsis is a risk, and Vd may be raised by resuscitation fluid.
- Clearance is reduced, so extend the dosing interval (or avoid repeat doses) guided by levels.
- Toxicity (nephro and oto) relates to trough exposure; efficacy to peak (concentration-dependent killing).
- 4.
Explain the difference between first-order and zero-order kinetics with clinical examples.
Show answer
- First-order: constant fraction removed per unit time; constant half-life; exponential decline; linear on log plot.
- Zero-order: constant amount removed per unit time; enzymes saturated; half-life rises with concentration.
- Examples: ethanol (about 7 to 10 g per hour in an adult, roughly one standard drink), phenytoin within the therapeutic range, salicylate and paracetamol in overdose.
- Michaelis-Menten: rate = Vmax × C ÷ (Km + C).
- Consequence: small dose changes cause disproportionate level changes; prolonged toxicity.
- 5.
How long does it take to reach steady state, and how can you get there faster?
Show answer
- About 4 to 5 elimination half-lives regardless of dose or interval (first-order drugs).
- Loading dose achieves target concentration immediately; then maintenance dose sustains it.
- Example: digoxin (t½ about 36 hours) takes about a week without loading; amiodarone months.
- If half-life is prolonged (renal failure for digoxin), time to steady state is longer too.
- 6.
What is hepatic extraction ratio and why does it matter for a patient in shock?
Show answer
- Fraction of drug removed in one pass through the liver; hepatic clearance = Q × ER.
- High ER drugs (lignocaine, morphine, propranolol): clearance depends on hepatic blood flow, which falls in shock, heart failure and with beta blockers, so levels rise.
- Low ER drugs (warfarin, phenytoin, theophylline): clearance depends on enzyme capacity and free fraction; sensitive to induction, inhibition and protein binding.
- Example: lignocaine toxicity more likely in cardiogenic shock.
- 7.
Draw the concentration-time curve after an IV bolus of a drug that follows a two-compartment model.
Show answer
- Log concentration on y axis, time on x axis.
- Rapid initial fall (alpha, distribution phase) then a straight line (beta, elimination phase).
- Back-extrapolate the beta line to y intercept; slope gives k and the elimination half-life.
- Mention context-sensitive half-time for infused lipophilic drugs, where redistribution governs offset.
- 8.
Which properties make a drug removable by haemodialysis? Give examples from toxicology.
Show answer
- Low molecular weight, low protein binding, small Vd (under about 1 L/kg), water soluble, and a clearance by dialysis that adds meaningfully to endogenous clearance.
- Examples: lithium, salicylate, toxic alcohols and their metabolites, metformin lactic acidosis, valproate and carbamazepine at high levels, theophylline.
- Not removed usefully: tricyclics, digoxin, amiodarone, benzodiazepines, calcium channel blockers (large Vd or high protein binding).
- 9.
Why does fentanyl wear off quickly after a single dose but slowly after a long infusion?
Show answer
- Highly lipid soluble; after a bolus the effect ends by redistribution from brain and plasma into muscle and fat.
- During a long infusion peripheral compartments fill; when stopped, drug returns from them to plasma.
- Context-sensitive half-time rises with infusion duration (fentanyl markedly; remifentanil constant because of esterase metabolism).
- Elimination half-life alone does not predict offset of lipophilic drugs.
Practise this week
- Primary Pharmacopoeia
- Physiology Bench: move the graphs yourself
- Primary Written SCQs in the ED bank
- Primary Viva stations
Week 2 in the other subjects
- Anatomy: Peripheral nerves, plexuses and muscle
- Pathology: Acute inflammation
- Physiology: Membrane potentials and the action potential
Not affiliated with the Australasian College for Emergency Medicine. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.